CASTELLI, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 663
EU - Europa 85
AS - Asia 21
OC - Oceania 2
SA - Sud America 2
AF - Africa 1
Totale 774
Nazione #
US - Stati Uniti d'America 660
IT - Italia 50
SE - Svezia 7
KR - Corea 5
DE - Germania 4
GB - Regno Unito 4
ES - Italia 3
FI - Finlandia 3
TR - Turchia 3
AU - Australia 2
BE - Belgio 2
CA - Canada 2
FR - Francia 2
HK - Hong Kong 2
IL - Israele 2
JP - Giappone 2
NL - Olanda 2
RS - Serbia 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
BR - Brasile 1
BS - Bahamas 1
CN - Cina 1
DK - Danimarca 1
ID - Indonesia 1
IE - Irlanda 1
IN - India 1
KZ - Kazakistan 1
LU - Lussemburgo 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 774
Città #
Chandler 229
Princeton 140
New York 57
Olbia 7
Sassari 7
Milan 5
Seoul 5
Frankfurt am Main 4
Lipari 4
Helsinki 3
San Mateo 3
Amsterdam 2
Ashburn 2
Belgrade 2
Brussels 2
Cormeilles-en-Parisis 2
Edinburgh 2
Hong Kong 2
Los Angeles 2
Madrid 2
Monserrato 2
Nuoro 2
Quartu Sant'Elena 2
Rome 2
San Francisco 2
Stockholm 2
Tel Aviv 2
Tokyo 2
Toronto 2
Almaty 1
Arona 1
Bratislava 1
Brisbane 1
Buenos Aires 1
Copenhagen 1
Cornaredo 1
Dublin 1
Guadalajara 1
Haikou 1
Hyderabad 1
Johannesburg 1
Las Vegas 1
Laurel 1
Manila 1
Mīrpur 1
Nassau 1
Oklahoma City 1
Rio de Janeiro 1
SantAntioco 1
Sesto San Giovanni 1
St Petersburg 1
Surabaya 1
Sydney 1
Tappahannock 1
Tukwila 1
Uta 1
Totale 527
Nome #
A Diagnostic of Acquired Hemophilia Following PD1/PDL1 Inhibitors in Advanced Melanoma: The Experience of Two Patients and a Literature Review 31
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants 26
Angioedema due to acquired C1-inhibitor deficiency : a bridging condition between autoimmunity and lymphoproliferation 24
Biosimilar epoetin alfa increases haemoglobin levels and brings cognitive and socio-relational benefits to elderly transfusion-dependent multiple myeloma patients: results from a pilot study 23
Incidence of Venous Thromboembolism in Multiple Myeloma Patients across Different Regimens: Role of Procoagulant Microparticles and Cytokine Release 23
Clinical Characteristics and treatment outcome of an 86-year old patient with acute myeloid leukemia with acute promyelocytic - like morphology and uncommon RARA fusion variant 22
Does Outcome/Survival of Patients With Myelodysplastic Syndromes Should Be Predicted by Reduced Levels of ADAMTS-13? Results From a Pilot Study 22
High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation 21
Thromboembolic complications in malignant haematological disorders 20
Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients 20
The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity 20
Bendamustine and Rituximab, as First Line Treatment, in Intermediate, High Risk Splenic Marginal Zone Lymphomas of Elderly Patients 19
Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterization 19
Current and Emerging Treatment Options for Patients with Relapsed Myeloma 18
Immunomodulatory drugs in multiple myeloma : from molecular mechanisms of action to clinical practice 18
Bendamustine in association with rituximab for first-line treatment of diffuse large B-cell lymphoma in frail patients ineligible for R-CHOP/R-CHOP-like treatments 18
Abnormal Hemostatic Parameters and Risk of Thromboembolism Among Patients With COVID-19 Infection 18
Cancer and thromboembolism: from biology to clinics 17
Aggressive natural killer cell leukaemia with a complex karyotype: a case report 17
Choosing treatment options for patients with relapsed/refractory multiple myeloma 17
Aggressive natural killer cell leukaemia with a complex karyotype: a case report 17
Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review 16
Acquired C1-inhibitor deficiency and lymphoproliferative disorders : a tight relationship 16
Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management 16
Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update 16
Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects 16
Ferric Carboxymaltose and Erythropoiesis-Stimulating Agent Treatment Reduces the Rate of Blood Transfusion in Refractory Anemia 15
Anti-t-PA antibodies in acute myocardial infarction after thrombolysis with rt-PA 15
High rate of hepatitis B viral breakthrough in elderly non-Hodgkin lymphomas patients treated with Rituximab based chemotherapy 15
Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate 15
The impact of an aging population on the diagnosis of pulmonary embolism: comparison of young and elderly patients 15
Concomitant use of Tyrosine-Kinase Inhibitor and Mepolizumab in Asthma Secondary to Chronic Myeloid Leukemia with Hypereosinophilia 14
Complement Activation in Patients With Immune Thrombocytopenic Purpura According to Phases of Disease Course 14
High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibtor deficiency 14
Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia 14
Biosimilar epoetin in elderly patients with low risk myelodisplastic syndromes improves anaemia, quality of life and brain function 12
Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor 12
First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas 12
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis 11
Hiv-Related Lymphoprolipherative Diseases In The Era Of Combination Antiretroviral Therapy 11
Midline peripheral catheters inserted in the superficial femoral vein at mid-thigh: Wise choice in COVID-19 acute hypoxemic respiratory failure patients with helmet continuous positive airway pressure 10
Aging of the Arterial System 10
Prothrombotic and inflammatory markers in elderly patients with non-alcoholic hepatic liver disease before and after weight loss: A pilot study 9
Management of anaemia in onco-haematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective study 9
Brachial Tunneled Peripherally Inserted Central Catheters and the Risk of Catheter Complications: A Systematic Review and Meta-Analysis 5
Platelet Microvesicles, Inflammation, and Coagulation Markers: A Pilot Study 5
Possible Effect of Polycystic Ovary Syndrome (PCOS) on Cardiovascular Disease (CVD): An Update 5
Thrombosis and hemostatic Abnormalities in haematological malignancies 5
Immunomodulatory drugs : new options for the treatment of myelodysplastic syndromes 5
Rheumatoid factors : clinical applications 5
Interaction of C1 inhibitor with thrombin on the endothelial surface 5
Pulmonary embolism in elderly patients: prognostic impact of the Cumulative Illness Rating Scale (CIRS) on short-term mortality 4
The value of four-detector row spiral computed tomography for the diagnosis of pulmonary embolism 4
Syncope in patients with pulmonary embolism: comparison between patients with syncope as the presenting symptom of pulmonary embolism and patients with pulmonary embolism without syncope 4
The heparins and cancer: review of clinical trials and biological properties 4
Intrathoracic masses due to extramedullary hematopoiesis 4
Risk-tailored treatment of splenic marginal zone lymphoma 4
ADAMTS13, von Willebrand Factor, Platelet Microparticles, Factor VIII, and Impact of Somatic Mutations in the Pathogenesis of Splanchnic Vein Thrombosis Associated with BCR-ABL-Negative Myeloproliferative Neoplasms 4
Massive Right Atrial Thrombosis: Are You Brave Enough to Start Anticoagulation? A Case Report 3
Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation 3
Laboratory and clinical risk assessment to treat myelodysplatic syndromes 3
Unusual severe development of common B lymphoblastic leukemia in Gaucher disease type I 3
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical praticeguidelineupdate 3
The impact of anaemia, transfusion dependency, commorbidities and polypharmacy in elderly patients with low-risk myelodysplastic syndromes 3
High Rate of hepatitis B viral breakthrought in elderly non Hodgkin lymphomas patients treated with Rituximab based chemotherapy 3
Lymphoproliferative disease and acquired C1 inhibitor deficiency 3
Salvage therapy with bortezomib and dexamethasone in elderly patients with relapsed/refractory multiple myeloma 3
Unreliable estimation of HbA due to the presence of Camperdown haemoglobin [beta 104 (G6) Arg --> Ser] 3
Inflammatory and prothrombotic parameters in normotensive non-diabetic obese women : effect of weight loss obtained by gastric banding 3
New antithrobotic agents 3
Managment of anemia in low risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents newer and older agents 3
Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies : from pathophysiology to the clinic 3
Ibrutinib related bleeding complications in elderly patients with lymphoprolipherative disease 3
Successful management with intravenous immunoglobulins in alemtuzumab-induced acute inflammatory demyelinating neuropathy : clinical report of three patients 3
Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency : clinical and molecular characterization 3
Effect of hydroxyurea on extramedullary haematopoiesis in thalassaemia intermedia : case reports and literature review 3
Personalized treatment strategies for elderly patients with myelodysplastic syndromes 3
Risk Of Thrombosis In Elderly Immune Primary Trombocytopenic Patients Treated With Thrombopoietin Receptors Agonists 3
Integrated short peripheral intravenous cannulas and risk of catheter failure: A systematic review and meta-analysis 2
Totale 862
Categoria #
all - tutte 9.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.641


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022202 0 0 0 0 0 0 84 0 3 4 21 90
2022/2023516 70 0 2 85 50 77 0 85 96 8 25 18
2023/2024144 26 22 5 3 8 57 2 10 0 6 5 0
Totale 862